{
    "root": "eab30315-f199-40ea-a2f2-a70d138c2c60",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Dicyclomine Hydrochloride",
    "value": "20250319",
    "ingredients": [
        {
            "name": "DICYCLOMINE HYDROCHLORIDE",
            "code": "CQ903KQA31"
        },
        {
            "name": "ANHYDROUS LACTOSE",
            "code": "3SY5LH9PMK"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "FD&C BLUE NO. 1",
            "code": "H3R47K3TBD"
        },
        {
            "name": "GELATIN, UNSPECIFIED",
            "code": "2G86QN327L"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357"
        },
        {
            "name": "POTASSIUM HYDROXIDE",
            "code": "WZH3C48M4T"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        }
    ],
    "indications": "dicyclomine hydrochloride indicated treatment patients functional bowel/irritable bowel syndrome .",
    "contraindications": "must adjusted individual patient needs .",
    "warningsAndPrecautions": "dicyclomine hydrochloride capsules , usp available containing 10 mg dicyclomine hydrochloride , usp . 10 mg capsules hard-shell gelatin capsule . 4 , light turquoise blue opaque cap light turquoise blue opaque body , hard-shell gelatin capsule filled white off-white powder . capsule axially printed \u2018 dil \u2019 cap \u2018 10 \u2019 body black ink . available follows : bottles 30 capsules ndc 68788-8578-3 bottles 60 capsules ndc 68788-8578-6 bottles 90 capsules ndc 68788-8578-9 bottles 100 capsules ndc 68788-8578-1 store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) . [ usp controlled room temperature . ] prevent fading , avoid exposure direct sunlight . dispense tight , light-resistant container defined usp using child-resistant closure .",
    "adverseReactions": "dicyclomine hydrochloride contraindicated infants less 6 months age [ ] , nursing mothers [ ] patients : \u2022 unstable cardiovascular status acute hemorrhage \u2022myasthenia gravis [ ] \u2022glaucoma [ ] \u2022obstructive uropathy [ ] \u2022obstructive disease gastrointestinal tract [ ] \u2022severe ulcerative colitis [ ] \u2022reflux esophagitis",
    "indications_original": "Dicyclomine hydrochloride is indicated for the treatment of patients with functional bowel/irritable bowel syndrome.",
    "contraindications_original": "Dosage must be adjusted to individual patient needs.",
    "warningsAndPrecautions_original": "Dicyclomine Hydrochloride Capsules, USP are available containing 10 mg of dicyclomine hydrochloride, USP.\n                  The 10 mg capsules are a hard-shell gelatin capsule with a No. 4, light turquoise blue opaque cap and light turquoise blue opaque body, hard-shell gelatin capsule filled with a white to off-white powder. The capsule is axially printed with \u2018DIL\u2019 on cap and \u201810\u2019 on body in black ink. They are available as follows:\n                  Bottles of 30 capsules\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NDC 68788-8578-3\n                  Bottles of 60 capsules\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NDC 68788-8578-6\n                  Bottles of 90 capsules\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NDC 68788-8578-9\n                  Bottles of 100 capsules\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NDC 68788-8578-1\n                  \n                     Store at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F). [See USP Controlled Room Temperature.]\n                  \n                  \n                     To prevent fading, avoid exposure to direct sunlight.\n                  \n                  \n                     Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.",
    "adverseReactions_original": "Dicyclomine hydrochloride is contraindicated in infants less than 6 months of age [see ], nursing mothers [see ] and in patients with:\n                  \n                     \n                        \u2022\n                        unstable cardiovascular status in acute hemorrhage\n                     \n                     \n                        \u2022myasthenia gravis [see \n                        ]\n                     \n                     \n                        \u2022glaucoma [see\u00a0 and ]\n                     \n                     \n                        \u2022obstructive uropathy [see \n                        ]\n                     \n                     \n                        \u2022obstructive disease of the gastrointestinal tract [see \n                        ]\n                     \n                     \n                        \u2022severe ulcerative colitis [see \n                        ]\n                     \n                     \n                        \u2022reflux esophagitis"
}